DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $175 | -14.6% | 12,429 | -6.5% | 0.01% | -6.7% |
Q1 2023 | $205 | -5.5% | 13,288 | +0.4% | 0.02% | -16.7% |
Q4 2022 | $217 | -99.9% | 13,239 | -4.7% | 0.02% | -25.0% |
Q3 2022 | $257,000 | +8.9% | 13,887 | -22.6% | 0.02% | +14.3% |
Q2 2022 | $236,000 | +20.4% | 17,953 | -15.3% | 0.02% | +250.0% |
Q1 2022 | $196,000 | +12.0% | 21,190 | +18.2% | 0.01% | 0.0% |
Q4 2021 | $175,000 | – | 17,933 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |